Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Letrozole, Everolimus, and TRC105 in HR+/HER2- Breast Cancer
NCT02520063Phase 2Completed
- Sponsor
- University of Alabama at Birmingham
- Start
- Feb 2015
- Primary completion
- Dec 2022
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of carotuximab in breast cancer, sponsored by University of Alabama at Birmingham. Started Feb 2015; status: completed.
02
Drugs
carotuximab
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02520063.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02520063.